Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial. Journal of Current Biomedical Reports, [S. l.], v. 5, n. 1, p. 14–19, 2024. DOI: 10.61882/jcbior.5.1.279. Disponível em: https://mail.jcbior.com/index.php/JCBioR/article/view/279. Acesso em: 17 apr. 2026.